TY - JOUR
T1 - Surgical complications after minimally invasive oesophagectomy compared to open oesophagectomy for oesophageal cancer
T2 - A population-based, nationwide study in Finland
AU - Sirviö, Ville E.J.
AU - Räsänen, Jari V.
AU - Helminen, Olli
AU - Helmiö, Mika
AU - Huhta, Heikki
AU - Kallio, Raija
AU - Koivukangas, Vesa
AU - Kokkola, Arto
AU - Lietzen, Elina
AU - Meriläinen, Sanna
AU - Pohjanen, Vesa Matti
AU - Rantanen, Tuomo
AU - Ristimäki, Ari
AU - Saarnio, Juha
AU - Sihvo, Eero
AU - Tyrväinen, Tuula
AU - Uimonen, Mikko
AU - Valtola, Antti
AU - Kauppila, Joonas H.
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/7
Y1 - 2025/7
N2 - Introduction: Evidence on the safety of minimally invasive oesophagectomy (MIO) compared to open oesophagectomy (OO) in nationwide practice is lacking. The aim of this study was to compare surgical complications after MIO and OO in a nationwide, population-based, unselected cohort. Materials and methods: Descriptive statistics were used to report complications and complication categories defined by the Oesophagectomy Complications Consensus Group, major complications, reoperations and 90-day mortality in all patients undergoing MIO and OO in Finland during 2007–2016. Main outcomes were compared using logistic regression, adjusting for confounding. Results: Out of 699 patients, 295 (42 %) underwent MIO and 404 (58 %) underwent OO. Rates of anastomotic leakage (10 % vs 14 %, OR 0.47 (0.25–0.89)), intrathoracic abscesses (3 % vs 9 %, OR 0.13 (0.05–0.46)), major complications (35 % vs 47 %, OR 0.39 (0.25–0.60)) and reoperations (18 % vs 26 %, OR 0.43 (0.26–0.73)) were lower with MIO. Rates of pneumonia (16 % vs 27 %, OR 0.62 (0.38–1.03)), intra-abdominal abscesses (0.7 % vs 3.0 %, OR 0.20 (0.04–1.13)) and 90-day mortality (3.1 % vs 6.7 %, HR 0.48 (0.18–1.26)) were lower with MIO, but non-significant after adjustment. Pulmonary complications (36 % vs 46 %, OR 0.63 (0.41–0.96)) and infectious complications (11 % vs 22 %, OR 0.41 (0.23–0.73)) were less common with MIO, while rates of cardiac, gastrointestinal, urologic, thromboembolic, and neurologic complications were similar. Conclusion: This study suggests a significant reduction in various surgical complications in patients undergoing MIO compared to OO and that implementing MIO into nationwide practice can be done safely.
AB - Introduction: Evidence on the safety of minimally invasive oesophagectomy (MIO) compared to open oesophagectomy (OO) in nationwide practice is lacking. The aim of this study was to compare surgical complications after MIO and OO in a nationwide, population-based, unselected cohort. Materials and methods: Descriptive statistics were used to report complications and complication categories defined by the Oesophagectomy Complications Consensus Group, major complications, reoperations and 90-day mortality in all patients undergoing MIO and OO in Finland during 2007–2016. Main outcomes were compared using logistic regression, adjusting for confounding. Results: Out of 699 patients, 295 (42 %) underwent MIO and 404 (58 %) underwent OO. Rates of anastomotic leakage (10 % vs 14 %, OR 0.47 (0.25–0.89)), intrathoracic abscesses (3 % vs 9 %, OR 0.13 (0.05–0.46)), major complications (35 % vs 47 %, OR 0.39 (0.25–0.60)) and reoperations (18 % vs 26 %, OR 0.43 (0.26–0.73)) were lower with MIO. Rates of pneumonia (16 % vs 27 %, OR 0.62 (0.38–1.03)), intra-abdominal abscesses (0.7 % vs 3.0 %, OR 0.20 (0.04–1.13)) and 90-day mortality (3.1 % vs 6.7 %, HR 0.48 (0.18–1.26)) were lower with MIO, but non-significant after adjustment. Pulmonary complications (36 % vs 46 %, OR 0.63 (0.41–0.96)) and infectious complications (11 % vs 22 %, OR 0.41 (0.23–0.73)) were less common with MIO, while rates of cardiac, gastrointestinal, urologic, thromboembolic, and neurologic complications were similar. Conclusion: This study suggests a significant reduction in various surgical complications in patients undergoing MIO compared to OO and that implementing MIO into nationwide practice can be done safely.
KW - Minimally invasive oesophagectomy
KW - Minimally invasive surgery
KW - Oesophageal cancer
KW - Oesophagectomy
KW - Surgery
KW - Surgical complications
U2 - 10.1016/j.ejso.2025.110093
DO - 10.1016/j.ejso.2025.110093
M3 - Article
AN - SCOPUS:105004816246
SN - 0748-7983
VL - 51
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 7
M1 - 110093
ER -